Status:
UNKNOWN
Antigenic and Antibody Detection of Candida
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
To Evaluate the Diagnostic Value of Candida Antigen Antibody Detection for Candida Infection
Eligibility:
All Genders
18-85 years
Brief Summary
In this study, a multicenter, prospective, synchronous blind, and controlled study was adopted to set the cut-off values of candida specific IgG, IgM, and Mn with the blood culture results as the gold...
Eligibility Criteria
Inclusion
- Age: (1) 18-85 years old; (2) Candida positive in aseptic humoral culture
- \-
Exclusion
- (1) no informed consent has been signed; (2) patients with severe immune deficiency -
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03766932
Start Date
January 1 2018
End Date
December 31 2020
Last Update
December 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital
Beijing, Beijing Municipality, China, 100853